(Q45644070)

14 December 2017

title

Modified vaccinia virus Ankara as a vaccine against feline coronavirus: immunogenicity and efficacy (English)

1 reference

14 December 2017

vaccinia virus

1 reference

feline coronavirus

1 reference

Véronique Duquesne

2

0 references

author name string

Matthias Hebben

1

1 reference

14 December 2017

Joëlle Cronier

3

1 reference

14 December 2017

Bernard Rossi

4

1 reference

14 December 2017

André Aubert

5

1 reference

14 December 2017

publication date

1 April 2004

1 reference

Journal of Feline Medicine and Surgery

14 December 2017

published in

1 reference

14 December 2017

volume

6

1 reference

14 December 2017

issue

2

1 reference

14 December 2017

page(s)

111-118

1 reference

Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines.

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2003.12.011

The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2003.12.011

Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2003.12.011

Poxviral mimicry of complement and chemokine system components: what's the end game?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2003.12.011

A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2003.12.011

Virologic and immunologic aspects of feline infectious peritonitis virus infection

21 January 2018

2 references

https://api.crossref.org/works/10.1016%2FJ.JFMS.2003.12.011

21 January 2018

12 December 2020

Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2003.12.011

Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2003.12.011

The prime-boost strategy: exciting prospects for improved vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2003.12.011

Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2003.12.011

Nonreplicating vaccinia vector efficiently expresses recombinant genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2003.12.011

Primary structure of the membrane and nucleocapsid protein genes of feline infectious peritonitis virus and immunogenicity of recombinant vaccinia viruses in kittens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2003.12.011

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2003.12.011

Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization

21 January 2018

1 reference

PubMed

12 December 2020

Pathogenicity studies of feline coronavirus isolates 79-1146 and 79-1683.

1 reference

PubMed

12 December 2020

Interleukin-18: a novel cytokine that augments both innate and acquired immunity

1 reference

PubMed

12 December 2020

10.1016/J.JFMS.2003.12.011

Identifiers

DOI

1 reference

14 December 2017

0 references

1 reference